Proof of Usefulness Report

Deigma

Analysis completed on 2/28/2026

+296

Proof of Usefulness Score

Gaining Momentum

Deigma is a verified French healthtech startup (est. 2019) providing IoT-based blood sample traceability solutions. While the project has high real-world utility and a confirmed partnership with Roche (navify ecosystem), the submission itself is of very poor quality, containing factual errors ('audience: everyone', 'most people have used my product') and suspicious placeholders. The low score reflects the disparity between the verified B2B potential and the unreliable submission data.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+27.0

Audience Reach Impact+4.8

Technical Innovation+12.0

Evidence Of Traction+12.5

Market Timing Relevance+8.5

Functional Completeness+0.25

Subtotal+65.05

Usefulness Multiplierx0.91

Final Score+296

Project Details

Project URL

deigma.fr

Description

Deigma has developed a pre-analytical solution for the traceability of blood samples for medical laboratories. Deigma has created an IoT platform 1) to improve the quality of blood samples which is not guaranteed today and 2) to improve the pre-analytical logistics which is a pain point for laboratories and results in a loss of time and money.

Algorithm Insights

Market Position

Growing utility with room for optimization

User Engagement

Documented reach suggests active user community

Technical Stack

Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline